Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Balk

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
JAMA Oncology|July 17, 2015
Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?Mary-Ellen Taplin, Steven P Balk
Cancer Cell|December 12, 2018
Initiation and Evolution of Early Onset Prostate CancerJoshua W Russo, Steven P Balk
Nuclear Receptor Signaling|February 28, 2008
AR, the cell cycle, and prostate cancerSteven P Balk, Karen E Knudsen
Translational Andrology and Urology|January 13, 2015
Androgen receptor epigeneticsChangmeng Cai, Xin Yuan, Steven P Balk
Current Opinion in Oncology|March 21, 2019
Targeting the androgen receptor and overcoming resistance in prostate cancerDavid J Einstein, Seiji Arai, Steven P Balk
Cancer Discovery|November 3, 2019
Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1Joshua W Russo, Mannan Nouri, Steven P Balk
Current Protocols in Immunology|September 4, 2010
Isolation and functional use of human NKT cellsMark A Exley, Brian Wilson, Steven P Balk
The Journal of Biological Chemistry|January 26, 2012
Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activationShaoyong Chen, Sarah Gulla, Changmeng Cai, et al.
Current Protocols in Immunology|November 2, 2017
Isolation and Functional Use of Human NKT CellsMark A Exley, S Brian Wilson, Steven P Balk
Cancer Cell|February 12, 2015
Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2Stephen R Plymate, Rupal S Bhatt, Steven P Balk
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
JAMA Oncology|July 17, 2015
Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?Mary-Ellen Taplin, Steven P Balk
Cancer Cell|December 12, 2018
Initiation and Evolution of Early Onset Prostate CancerJoshua W Russo, Steven P Balk
Nuclear Receptor Signaling|February 28, 2008
AR, the cell cycle, and prostate cancerSteven P Balk, Karen E Knudsen
Translational Andrology and Urology|January 13, 2015
Androgen receptor epigeneticsChangmeng Cai, Xin Yuan, Steven P Balk
Current Opinion in Oncology|March 21, 2019
Targeting the androgen receptor and overcoming resistance in prostate cancerDavid J Einstein, Seiji Arai, Steven P Balk
Cancer Discovery|November 3, 2019
Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1Joshua W Russo, Mannan Nouri, Steven P Balk
Current Protocols in Immunology|September 4, 2010
Isolation and functional use of human NKT cellsMark A Exley, Brian Wilson, Steven P Balk
The Journal of Biological Chemistry|January 26, 2012
Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activationShaoyong Chen, Sarah Gulla, Changmeng Cai, et al.
Current Protocols in Immunology|November 2, 2017
Isolation and Functional Use of Human NKT CellsMark A Exley, S Brian Wilson, Steven P Balk
Cancer Cell|February 12, 2015
Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2Stephen R Plymate, Rupal S Bhatt, Steven P Balk
Pageof 19